Evaluation of BRD4 Inhibitors for Use in Combination with Kinase Inhibitors for NF2 Schwannomas

syn35632706

Created By NF Service nf-osi-service

dataType: image raw counts
grantDOI: https://doi.org/10.48105/pc.gr.154746
studyName: Evaluation of BRD4 Inhibitors for Use in Combination with Kinase Inhibitors for NF2 Schwannomas
dataStatus: Under Embargo
initiative: Young Investigator Award
studyLeads: Haley Hardin
studyStatus: Active
diseaseFocus: Neurofibromatosis type 2
grantEndDate: 1725062400000
institutions: University of Central Florida Research Foundation
fundingAgency: CTF
embargoEndDate: 1756598400000
grantStartDate: 1654041600000
relatedStudies: syn51907739 syn26383473 syn26238842 syn27261829
studyFileviewId: syn35632727
syn35632718
syn64024712
syn64130387
syn63923300
syn64130455
syn64574672
syn35632720
syn63921253
syn35632727
syn35632721
syn63912545

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Evaluation of BRD4 Inhibitors for Use in Combination with Kinase Inhibitors for NF2 Schwannomas

syn35632706

Drop files to upload

Evaluation of BRD4 Inhibitors for Use in Combination with Kinase Inhibitors for NF2 Schwannomas page is loading…